Evidence map›Paper›PMID 27468719›Full record

ArticleTumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine2016

Tumor biology of non-metastatic stages of clear cell renal cell carcinoma; overexpression of stearoyl desaturase-1, EPO/EPO-R system and hypoxia-related proteins.

Tania Romina Stoyanoff, Juan Pablo Rodríguez, Juan Santiago Todaro, Joaquín Diego Espada, Juan Pablo Melana Colavita, Nora Cristina Brandan, Adriana Mónica Torres, María Victoria Aguirre

Abstract read
PubMed Publisher
In one paragraph

Article in Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 21 citations in OpenAlex.

  1. Regulation of Erythropoietin Activity in Clear Renal Cell Carcinoma.International journal of molecular sciences · 2025
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Ferroptosis Signaling and Regulators in Atherosclerosis.Frontiers in cell and developmental biology · 2021
    Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Tania Romina StoyanoffLaboratory of Biochemical Investigations (LIBIM), Basic Medical Sciences Department, School of Medicine, National Northeastern University (UNNE), IQUIBA-CONICET, Moreno 1240, 3400, Corrientes, Argentina.
Juan Pablo RodríguezLaboratory of Biochemical Investigations (LIBIM), Basic Medical Sciences Department, School of Medicine, National Northeastern University (UNNE), IQUIBA-CONICET, Moreno 1240, 3400, Corrientes, Argentina.
Juan Santiago TodaroLaboratory of Biochemical Investigations (LIBIM), Basic Medical Sciences Department, School of Medicine, National Northeastern University (UNNE), IQUIBA-CONICET, Moreno 1240, 3400, Corrientes, Argentina.
Joaquín Diego EspadaDepartment of Urology, J.R. Vidal Hospital, Corrientes, Argentina.
Juan Pablo Melana ColavitaLaboratory of Biochemical Investigations (LIBIM), Basic Medical Sciences Department, School of Medicine, National Northeastern University (UNNE), IQUIBA-CONICET, Moreno 1240, 3400, Corrientes, Argentina.
Nora Cristina BrandanLaboratory of Biochemical Investigations (LIBIM), Basic Medical Sciences Department, School of Medicine, National Northeastern University (UNNE), IQUIBA-CONICET, Moreno 1240, 3400, Corrientes, Argentina.
Adriana Mónica TorresPharmacology, Faculty of Biochemical and Pharmaceutical Sciences, National University of Rosario (UNR), CONICET, Rosario, Argentina.
María Victoria AguirreLaboratory of Biochemical Investigations (LIBIM), Basic Medical Sciences Department, School of Medicine, National Northeastern University (UNNE), IQUIBA-CONICET, Moreno 1240, 3400, Corrientes, Argentina. mvaguirre@med.unne.edu.ar.
Consejo Nacional de Investigaciones Científicas y Técnicas · ARNational University of the Northeast · ARNational University of Rosario · AR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Clear cell renal cell carcinoma (ccRCC) is the most common subtype of renal carcinomas. There is great interest to know the molecular basis of the tumor biology of ccRCC that might contribute to a better understanding of the aggressive biological behavior of this cancer and to identify early biomarkers of disease. This study describes the relationship among proliferation, survival, and apoptosis with the expression of key molecules related to tumoral hypoxia (hypoxia-inducible factor (HIF)-1α, erythropoietin (EPO), vascular endothelial growth factor (VEGF)), their receptors (EPO-R, VEGFR-2), and stearoyl desaturase-1 (SCD-1) in early stages of ccRCC. Tissue samples were obtained at the Urology Unit of the J.R. Vidal Hospital (Corrientes, Argentina), from patients who underwent radical nephrectomy for renal cancer between 2011 and 2014. Four experimental groups according to pathological stage and nuclear grade were organized: T1G1 (n = 6), T2G1 (n = 4), T1G2 (n = 7), and T2G2 (n = 7). The expression of HIF-1α, EPO, EPO-R, VEGF, VEGFR-2, Bcl-x

Indexed as

AdultAgedAged, 80 and overApoptosisBiomarkers, TumorBlotting, WesternCarcinoma, Renal CellCell ProliferationErythropoietinFemaleHumansHypoxia-Inducible Factor 1, alpha SubunitImmunoenzyme TechniquesKidney NeoplasmsMaleMiddle AgedBiomarkers, TumorEPO protein, humanErythropoietinHIF1A protein, humanHypoxia-Inducible Factor 1, alpha SubunitReceptors, ErythropoietinRNA, MessengerStearoyl-CoA DesaturaseVascular Endothelial Growth Factor AVascular Endothelial Growth Factor Receptor-2VEGFA protein, humanApoptosisClear cell renal cell carcinoma (ccRCC)EPO receptor (EPO-R)Erythropoietin (EPO)Stearoyl desaturase-1 (SCD-1)

Identifiers

PMID27468719
OpenAlexW2502621236

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.